News

Media And Political Bulletin – 25 February 2019

Media and Political Bulletin

25 February 2019

Media Summary

Health leaders call on Prime Minister to prevent ‘no-deal’ Brexit

HSJ, Jack Serle, 22 February 2019

HSJ reports that health leaders have signed a letter calling on the Prime Minister to prevent a no-deal Brexit.

The letter said its signatories were “increasingly alarmed at the risks associated with a ‘no-deal’ Brexit”. It stated there are immediate concerns around the supply of medicines, devices and other essential medical products.

The letter, which was coordinated by the patient voice charity National Voices, has been signed by senior figures from the health professions, third sector, and health service.

 

Parliamentary Coverage

House of Commons Questions – 22 February 2019

Bambos Charalambous (Enfield, Southgate): To ask the Secretary of State for Health and Social Care, what plans he has in place to (a) (i) monitor and (ii) identify gaps in the medicines being stockpiled by pharmaceutical companies and (b) protect the supply of medicines not being stockpiled by pharmaceutical companies.

Stephen Hammond: In August 2018, the Department asked suppliers to confirm arrangements in respect of prescription-only and pharmacy medicines that come from or via the European Union /European Economic Area. Company responses have provided the Department with an indication of industry’s ability and preparedness to stockpile six weeks’ worth of additional supply of each of the in-scope medicines in the United Kingdom ahead of 29 March 2019.

Since then, we have continued to receive very good engagement and are working closely with industry on a product-by-product basis. Companies share our aims of ensuring continuity of medicines supply for patients is maintained and that suppliers are able to cope with any potential delays at the border that may arise in the short term in a ‘no deal’ scenario.

 

Chris Evans (Islwyn): To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure the continuation of healthcare packages for all patients currently qualifying for such packages in the event that the UK leaves the EU without a deal.

Stephen Hammond: As we prepare to leave the European Union, the Government is planning for all scenarios, including the event that the United Kingdom leaves the EU without a deal.

Our priority is to minimise disruption to the health and social care system, including ensuring continuity of access to health and care services for patients after the UK leaves the EU. This includes continued engagement with health and social care employers across the sectors to provide a seamless supply of medicines and medical products from the moment we leave the EU.

The UK Government appreciates the importance of retaining reciprocal healthcare arrangements with the EU and is seeking agreements with Member States, so that no individual will face sudden changes to their healthcare cover when we leave the EU.

 

Full Coverage

Health leaders call on Prime Minister to prevent ‘no-deal’ Brexit

HSJ, Jack Serle, 22 February 2019

Health leaders, including a former NHS Chief Executive, have signed a letter calling on the Prime Minister to prevent a no-deal Brexit.

The letter said its signatories were “increasingly alarmed at the risks associated with a ‘no-deal’ Brexit”. They called on Theresa May to work with Parliament and the European Union to prevent the UK from leaving the EU without a deal.

The letter, which was coordinated by the patient voice charity National Voices, has been signed by senior figures from the health professions, third sector, and health service.

These include former NHS Chief Executive Sir David Nicholson, Chair of the Royal College of General Practitioners Helen Stokes-Lampard, Chair of the Tavistock and Portman Foundation Trust and former Health minister Paul Burstow, Chief Executive of The Queen’s Nursing Institute Crystal Oldman and Lord Darzi of Denham.

“As the government’s contingency planning demonstrates, a ‘no-deal’ Brexit poses grave risks to public health and patient safety, and would require extraordinary measures in mitigation,” the letter said.

The document stated there are immediate concerns around the supply of medicines, devices and other essential medical products.

“But a ‘no-deal’ exit would also have serious implications for the availability of staff in care and research settings, the arrangements governing reciprocal healthcare, the regulation of medicines and devices, and the UK’s involvement in pan-European research and innovation and in public health and prevention initiatives,” the letter added.

“All of these would be affected over an indefinite period of time. The most disadvantaged in society would be likely to be most at risk.”

Media And Political Bulletin – 25 February 2019

From Factory to Pharmacy

As part of our mission to build awareness, understanding and appreciation of the vital importance of the healthcare distribution sector, we developed an infographic explaining the availability of medicines. It identifies the factors that can impact drug supply, as well as the measures that HDA members undertake day in, day out to help mitigate the risks of patients not receiving their medicines.

See the Infographic

Apply to become a Member

Membership of the HDA guarantees your organisation:

  • Access to leading policy and industry forums of debate and discussion
  • Invitations to a range of networking industry events organised through the year, including an Annual Conference and a Business Day
  • Representation on HDA working parties, including the Members’ Liaison Group
  • A daily Political and Media Bulletin and HDA Newsletters
  • Access to HDA policy documents and all sections of the HDA website
  • Branding and marketing opportunities
Apply Now

Already a Member?